Selection for human immunodeficiency virus type I envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels

被引:217
作者
Chohan, B
Lang, D
Sagar, M
Korber, B
Lavreys, L
Richardson, B
Overbaugh, J
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[3] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[6] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[7] Los Alamos Natl Lab, Los Alamos, NM 87544 USA
关键词
D O I
10.1128/JVI.79.10.6528-6531.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Designing an effective human immunodeficiency virus type 1 (HIV-1) vaccine will rely on understanding which variants, from among the myriad of circulating HIV-1 strains, are most commonly transmitted and determining whether such variants have an Achilles heel. Here we show that heterosexually acquired subtype A HIV-1 envelopes have signature sequences that include shorter V1-V2 loop sequences and fewer predicted N-linked glycosylation sites relative to the overall population of circulating variants. In contrast, recently transmitted subtype B variants did not, and this was true for cases where the major risk factor was homosexual contact, as well as for cases where it was heterosexual contact. This suggests that selection during HIV-1 transmission may vary depending on the infecting subtype. There was evidence from 23 subtype A-infected women for whom there was longitudinal data that those who were infected with viruses with fewer potential N-linked glycosylation sites in V1-V2 had lower viral set point levels. Thus, our study also suggests that the extent of glycosylation in the infecting virus could impact disease progression.
引用
收藏
页码:6528 / 6531
页数:4
相关论文
共 17 条
[1]   Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies [J].
Chackerian, B ;
Rudensey, LM ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7719-7727
[2]   Selection for neutralization resistance of the simian human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation [J].
Cheng-Mayer, C ;
Brown, A ;
Harouse, J ;
Luciw, PA ;
Mayer, AJ .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5294-5300
[3]   A distinctive clade BHIV type 1 is heterosexually transmitted in Trinidad and Tobago [J].
Cleghorn, FR ;
Jack, N ;
Carr, JK ;
Edwards, J ;
Mahabir, B ;
Sill, A ;
McDanal, CB ;
Connolly, SM ;
Goodman, D ;
Bennetts, RQ ;
O'Brien, TR ;
Weinhold, KJ ;
Bartholomew, C ;
Blattner, WA ;
Greenberg, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10532-10537
[4]   Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission [J].
Derdeyn, CA ;
Decker, JM ;
Bibollet-Ruche, F ;
Mokili, JL ;
Muldoon, M ;
Denham, SA ;
Heil, ML ;
Kasolo, F ;
Musonda, R ;
Hahn, BH ;
Shaw, GM ;
Korber, BT ;
Allen, S ;
Hunter, E .
SCIENCE, 2004, 303 (5666) :2019-2022
[5]   Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B [J].
Frost, SDW ;
Liu, Y ;
Pond, SLK ;
Chappey, C ;
Wrin, T ;
Petropoulos, CJ ;
Little, SJ ;
Richman, DD .
JOURNAL OF VIROLOGY, 2005, 79 (10) :6523-6527
[6]   Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression [J].
Kimata, JT ;
Kuller, L ;
Anderson, DB ;
Dailey, P ;
Overbaugh, J .
NATURE MEDICINE, 1999, 5 (05) :535-541
[7]   Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women [J].
Lavreys, L ;
Baeten, JM ;
Kreiss, JK ;
Richardson, BA ;
Chohan, BH ;
Hassan, W ;
Panteleeff, DD ;
Mandaliya, K ;
Ndinya-Achola, JO ;
Overbaugh, J .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) :303-311
[8]   HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus [J].
Long, EM ;
Rainwater, SMJ ;
Lavreys, L ;
Mandaliya, K ;
Overbaugh, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (08) :567-576
[9]  
Long EM, 2000, NAT MED, V6, P71
[10]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170